Research Topics
Species | J N WeitzelSummaryAffiliation: City of Hope National Medical Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research NetworkJeffrey N Weitzel
City of Hope, Duarte, CA 91010, USA
J Clin Oncol 31:210-6. 2013..To determine the prevalence and type of BRCA1 and BRCA2 (BRCA) mutations among Hispanics in the Southwestern United States and their potential impact on genetic cancer risk assessment (GCRA)...
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2Anna Marie Mulligan
Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK
Breast Cancer Res 13:R110. 2011..It is currently unknown how these alleles are associated with different breast cancer subtypes in BRCA1 and BRCA2 mutation carriers defined by estrogen (ER) or progesterone receptor (PR) status of the tumour...
Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriersSusan L Neuhausen
Department of Epidemiology, University of California Irvine, 224 Irvine Hall, Irvine, CA 92697, USA
Breast Cancer Res 11:R76. 2009..In this study, we investigate the association of variants in genes involved in IGF signaling and risk of breast cancer in women who carry deleterious BRCA1 and BRCA2 mutations...
Limited family structure and BRCA gene mutation status in single cases of breast cancerJeffrey N Weitzel
Department of Clinical Cancer Genetics, City of Hope, 1500 E Duarte Rd, Duarte, CA 91010, USA
JAMA 297:2587-95. 2007..An autosomal dominant pattern of hereditary breast cancer may be masked by small family size or transmission through males given sex-limited expression...
Reduced mammographic density with use of a gonadotropin-releasing hormone agonist-based chemoprevention regimen in BRCA1 carriersJeffrey N Weitzel
Department of Clinical Cancer Genetics, City of Hope Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA
Clin Cancer Res 13:654-8. 2007..We evaluated the efficacy, safety, and tolerability of hormonal chemoprevention with a gonadotropin-releasing hormone agonist (GnRHA) with low-dose add-back steroids in BRCA1(mut) carriers...
Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic familiesJeffrey N Weitzel
Department of Clinical Cancer Genetics, City of Hope, 1500 East Duarte Road, Duarte, CA 91010, USA
Cancer Epidemiol Biomarkers Prev 16:1615-20. 2007..Large rearrangements account for 8% to 15% of deleterious BRCA mutations, although none have been characterized previously in individuals of Mexican ancestry...
Prevalence of BRCA mutations and founder effect in high-risk Hispanic familiesJeffrey N Weitzel
Department of Clinical Cancer Genetics, City of Hope Cancer Center, 1500 East Duarte Road, Mod 103, Duarte, CA 91010, USA
Cancer Epidemiol Biomarkers Prev 14:1666-71. 2005..Approximately 12% of the U.S. population is Hispanic, with the majority residing in urban centers such as Los Angeles. The prevalence of BRCA mutations among high-risk Hispanic families is unknown...
The current social, political, and medical role of genetic testing in familial breast and ovarian carcinomasJ N Weitzel
Department of Clinical Cancer Genetics, City of Hope National Medical Center, Duarte, CA 91010, USA
Curr Opin Obstet Gynecol 11:65-70. 1999..This article will consider recent advances in the understanding of cancer genetics, and describe the state-of-the-art in terms of management of individuals with inherited susceptibility to breast and ovarian cancer...
The HRAS1 minisatellite locus and risk of ovarian cancerJ N Weitzel
City of Hope National Medical Center and Beckman Research Institute, Duarte, California 91010 3000, USA
Cancer Res 60:259-61. 2000..Thus, the HRAS1-variable number of tandem repeats locus may function as a modifier of ovarian cancer risk in both sporadic and hereditary ovarian cancer...
Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosisJeffrey N Weitzel
Department of Clinical Cancer Genetics, City of Hope National Medical Center, Duarte, CA 91010, USA
Arch Surg 138:1323-8; discussion 1329. 2003..Breast cancer gene (BRCA) mutation status affects patients' surgical decisions when genetic cancer risk assessment is offered at the time of breast cancer diagnosis, prior to definitive treatment...
Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriersCarey A Cullinane
City of Hope National Medical Center, Duarte, CA, USA
Int J Cancer 117:988-91. 2005..Among BRCA2 carriers, increasing parity was associated with a significant increase in the risk of breast cancer before age 50 and this increase was greatest in the 2-year period following a pregnancy...
Social-cognitive aspects of underserved Latinas preparing to undergo genetic cancer risk assessment for hereditary breast and ovarian cancerVeronica I Lagos
Department of Clinical Cancer Genetics, City of Hope Cancer Center, Duarte, CA 91010, USA
Psychooncology 17:774-82. 2008..This study explores social, cognitive and cultural variables in Latinas prior to undergoing GCRA...
Beliefs and interest in cancer risk in an underserved Latino cohortCharité N Ricker
City of Hope National Medical Center, Clinical Cancer Genetics Department, Duarte, CA 91010, USA
Prev Med 44:241-5. 2007..To measure beliefs about cancer causation, cancer screening behaviors, access to information about and resources for cancer screening, and interest in cancer genetics services in two underserved predominantly Latino communities...
Restriction endonuclease fingerprinting enhanced conformation sensitive gel electrophoresis (REF-CSGE) in the analysis of BRCA1 exon 11 mutations in a high-risk breast cancer cohortJosef S Herzog
Department of Clinical Cancer Genetics, Beckman Research Institute and City of Hope (COH) Comprehensive Cancer Center, Duarte, California, USA
Hum Mutat 19:656-63. 2002..An analysis of the overall efficiency of both techniques revealed that REF-CSGE required 67% fewer confirmatory sequencing reactions, resulting in savings in both reagents and technician time...
Linkage of a pedigree drawing program and database to a program for determining BRCA mutation carrier probabilitySharon R Sand
Clinical Cancer Genetics, City of Hope Comprehensive Cancer Center, 1500 East Duarte Rd, Modular 103, Duarte, CA 9101, USA
Fam Cancer 4:313-6. 2005..An export module was developed for transferring primary relational pedigree data directly from a widely used pedigree program and relational database to the BRCAPRO program for calculation of BRCA gene mutation probability estimation...
Effects of a cancer genetics education programme on clinician knowledge and practiceK R Blazer
Department of Clinical Cancer Genetics, City of Hope Comprehensive Cancer Center and Beckman Research Institute, 1500 East Duarte Road, Duarte, CA 91010, USA
J Med Genet 41:518-22. 2004..Many clinicians lack adequate knowledge about emerging standards of care related to genetic cancer risk assessment and the features of hereditary cancer needed to identify patients at risk...
Development and evaluation of a decision aid for BRCA carriers with breast cancerJulie O Culver
Division of Clinical Cancer Genetics, Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, CA 91010 3000, USA
J Genet Couns 20:294-307. 2011..Stakeholders were divided as to whether the DA should be offered at-home versus only in a clinical setting. This well-received DA will be further tested to determine accessibility and effectiveness...
Comparison of Latina and non-Latina white women's beliefs about communicating genetic cancer risk to relativesDeborah J MacDonald
Cancer Screening and Prevention Program, Clinical Cancer Genetics Department, City of Hope Cancer Center, Duarte, California 91010 3000, USA
J Health Commun 13:465-79. 2008..15-5.66), Latina ethnicity (odds ratio [OR] 0.22, 95% CI, 0.09-0.53), and Spanish as primary language (OR, 0.17, 95% CI, 0.06-0.47) were independently associated with the belief that a clinician should be the informant...
Women's perceptions of the personal and family impact of genetic cancer risk assessment: focus group findingsDeborah J MacDonald
Division of Clinical Cancer Genetics, City of Hope Comprehensive Cancer Center, 1500 E Duarte Rd, Duarte, CA 91010 3000, USA
J Genet Couns 19:148-60. 2010..Additional research is needed to extend these findings and identify interventions to support positive outcomes of GCRA...
Creating tomorrow's leaders in cancer prevention: a novel interdisciplinary career development program in cancer genetics researchKathleen R Blazer
City of Hope Cancer Center, Duarte, CA 91010, USA
J Cancer Educ 21:216-22. 2006..To prepare oncology, genetics and molecular medicine professionals for basic, translational and epidemiological cancer genetics research through advanced training in a novel specialized cancer genetics career development program (CGCDP)...
Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer risk assessmentDeborah J MacDonald
Clinical Cancer Genetics Department, City of Hope Cancer Center, Duarte, California 91010 3000, USA
Genet Med 9:275-82. 2007..We compared women's selection of family members for cancer risk communication and perceived barriers to this communication before genetic cancer risk assessment and 6 months afterward...
Evolving perspectives on genetic discrimination in health insurance among health care providersCarin R Huizenga
Division of Clinical Cancer Genetics, City of Hope, 1500 East Duarte Road, Duarte, CA 91010, USA
Fam Cancer 9:253-60. 2010..Better knowledge of GD and protective legislation, may facilitate non-genetics clinician utilization of genetics and personalized medicine...
Assessing the predictive accuracy of hMLH1 and hMSH2 mutation probability modelsKory W Jasperson
Department of Clinical Cancer Genetics, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010 3000, USA
J Genet Couns 15:339-47. 2006..616 and 0.400, respectively). The results of this study demonsrate that neither the Wijnen model nor the Myriad table are sensitive or specific enough to be used as the only indication when to offer genetic testing for HNPCC...
Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancersDeborah J MacDonald
Clinical Cancer Genetics Department, City of Hope Cancer Center, Duarte, CA, USA
Oncol Nurs Forum 33:E27-35. 2006..To examine breast and ovarian cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment (GCRA)...
Development of a cancer genetics education program for cliniciansKathleen R Blazer
Department of Clinical Cancer Genetics, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, California 91010, USA
J Cancer Educ 17:69-73. 2002..There is a gap in knowledge about hereditary cancer and genetic testing among primary care practitioners. Education is needed to enable identification and management of patients at high risk for cancer...
Health beliefs of women with and without breast cancer seeking genetic cancer risk assessmentDeborah J MacDonald
Clinical Cancer Genetics Department, City of Hope Cancer Center, 1500 East Duarte Road, Duarte, CA 91010, USA
Cancer Nurs 28:372-9; quiz 380-1. 2005..Nurses are in a prime position to assist women seeking GCRA by providing accurate information and emotional support regarding cancer risk, risk factors, and genetic testing...
Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessmentPhuong L Mai
Department of Clinical Cancer Genetics, City of Hope National Medical Center, Duarte, CA, USA
Ann Surg Oncol 15:3415-21. 2008..In this study, we examined the use of CRRM before versus after genetic cancer risk assessment (GCRA) in women diagnosed with breast cancer before age 50...
Outcomes from intensive training in genetic cancer risk counseling for cliniciansKathleen R Blazer
Department of Clinical Cancer Genetics, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, California, USA
Genet Med 7:40-7. 2005..Courses such as this can help address the need for competent cancer risk assessment services in communities outside the academic health center...
Loss of five amino acids in BRCA2 is associated with ovarian cancerS L Martinez
Department of Clinical Cancer Genetics, Beckman Research Institute, CA, USA
J Med Genet 41:e18. 2004
Clinical and functional properties of novel VHL mutation (X214L) consistent with Type 2A phenotype and low risk of renal cell carcinomaA D Sorrell
City of Hope National Medical Center, Duarte, California 91010 3000, USA
Clin Genet 79:539-45. 2011..In contrast, this variant, like other pVHL variants linked to Type 2A disease, fails to suppress JunB. This underscores that JunB may play a role in the pathogenesis of Type 2A VHL disease...
Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposisKory W Jasperson
Cancer Screening and Prevention Program, City of Hope Cancer Center, Duarte, CA, USA
Fam Cancer 9:99-107. 2010..Careful attention to evolving or additional clinical features is warranted and may lead to an alternate genetic diagnosis in families with early onset CRC...
Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutationsKelly D Gonzalez
Departments of Molecular Diagnosis, Molecular Genetics, Clinical Cancer Genetics, and Information Sciences, and the Bioinformatics Group, City of Hope, Duarte, CA 91010 0269, USA
J Clin Oncol 27:1250-6. 2009..A clinical testing cohort was used to gain a broader understanding of the spectrum of tumors associated with germline p53 mutations to aid clinicians in identifying high-risk families...
Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among cliniciansKatrina J Lowstuter
Department of Clinical Cancer Genetics, City of Hope, Duarte, California 91010, USA
Genet Med 10:691-8. 2008..To describe nongenetics clinicians' perceptions and knowledge of cancer genetics and laws prohibiting genetic discrimination, attitudes toward the use of cancer genetic testing, and referral practices...
Genetic discrimination: the clinician perspectiveR Nedelcu
Department of Clinical Cancer Genetics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA
Clin Genet 66:311-7. 2004..Clinician concerns about potential genetic discrimination, and lack of information regarding protective legislation, may influence access to care...
Extending comprehensive cancer center expertise in clinical cancer genetics and genomics to diverse communities: the power of partnershipDeborah J MacDonald
Division of Clinical Cancer Genetics, City of Hope Comprehensive Cancer Center, Duarte, California 91010, USA
J Natl Compr Canc Netw 8:615-24. 2010....
Working through a diagnostic challenge: colonic polyposis, Amsterdam criteria, and a mismatch repair mutationKory W Jasperson
Department of Clinical Cancer Genetics, City of Hope National Medical Center, Duarte, CA, USA
Fam Cancer 7:281-5. 2008..We outline evidence supporting the pathogenicity of the identified hMSH6 mutation (arg772trp) and suggest possible etiologies for the unexplained colonic adenomatous polyposis...
Microsatellite instability is a rare finding in tumors of patients with both primary renal and rectal neoplasmsCarey A Cullinane
Department of Clinical Cancer Genetics, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010, USA
Cancer Genet Cytogenet 148:163-5. 2004....
A comparison of bilateral breast cancers in BRCA carriersJeffrey N Weitzel
The Centre for Research in Women s Health, 790 Bay Street, Toronto, Ontario, Canada M5G 1N8
Cancer Epidemiol Biomarkers Prev 14:1534-8. 2005..It is generally believed that the two cancers represent independent events. However, the extent of concordance between the first and second tumors with respect to hormone receptor expression and other pathologic features is unknown...
Genetic cancer risk assessment in the newly diagnosed breast cancer patient is useful and possible in practiceMelanie R Palomares
J Clin Oncol 23:3165-6; author reply 3166-7. 2005
Validity of models for predicting BRCA1 and BRCA2 mutationsGiovanni Parmigiani
The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland 21205 2011, USA
Ann Intern Med 147:441-50. 2007..At least 7 models for estimating the probabilities of having a mutation are used widely in clinical and scientific activities; however, the merits and limitations of these models are not fully understood...
Screening-detected breast cancer in a man with BRCA2 mutation: case reportR James Brenner
Eisenberg Keefer Breast Center, John Wayne Cancer Institute, Saint Johns Health Center, 1328 22nd St, Santa Monica, CA 90404, USA
Radiology 230:553-5. 2004..The authors discuss the clinical implications of this approach to detecting male breast cancer...
Genetic/familial high-risk assessment: breast and ovarianMary B Daly
Fox Chase Cancer Center, Philadelphia, PA, USA
J Natl Compr Canc Netw 4:156-76. 2006
Research Grants
- Genetic Discrimination Knowledge in Primary CareJeffrey Weitzel; Fiscal Year: 2004..Because genetic testing for hereditary cancer represents a new paradigm for predictive genetic testing in other adult onset disorders, the results of the proposed study will potentially have broad-based implications. ..
- CLINICAL CANCER GENETICS EDUCATIONJeffrey Weitzel; Fiscal Year: 2005..abstract_text> ..
- Community Cancer Genetics and Research Training (Revision)Jeffrey Weitzel; Fiscal Year: 2007..The curriculum and delivery design may serve as a model for dissemination to other cancer centers to help address NCI priorities such as augmentation of familial registries (e.g. Cooperative Family Studies) ..
- Cancer Genetics Career Development ProgramJeffrey Weitzel; Fiscal Year: 2007..The graduates of this program will reduce the burden of cancer among those at highest risk by translating cancer genetic epidemiology to individual risk assessment tools and acceptable interventions. ..
